Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials
Mihaela-Simona Popoviciu, Lorena Păduraru, Galal Yahya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10449-10449
Open Access | Times Cited: 103
Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Areesha Moiz, Jeremy Y. Levett, Kristian B. Filion, et al.
The American Journal of Cardiology (2024) Vol. 222, pp. 121-130
Open Access | Times Cited: 16
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
Jeffrey L. Cummings, Alireza Atri, Howard Feldman, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology (2025)
Open Access | Times Cited: 3
Semaglutide and cancer: A systematic review and meta-analysis
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 34
Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety
Alberte Laura Oest Müllertz, Rasmus Michael Sandsdal, Simon Birk Kjær Jensen, et al.
Obesity Reviews (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 14
Allocation of Semaglutide According to Coronary Artery Calcium and BMI
Alexander C. Razavi, Alexander M. Cao Zhang, Zeina Dardari, et al.
JACC. Cardiovascular imaging (2025)
Closed Access | Times Cited: 1
Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and evidence map
Tingting Lu, Bin Liu, Long Ge, et al.
International Journal of Obesity (2025)
Closed Access | Times Cited: 1
Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery
J. Ferguson, Oliver M. Fisher, Michael Talbot, et al.
Obesity Surgery (2025)
Open Access | Times Cited: 1
Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses
Monica Saumoy, Devika Gandhi, Seth Buller, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2250-2259
Closed Access | Times Cited: 19
Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials
David Lubasi Nalisa, Nelson Cuboia, Eman Dyab, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Outpatient management of essential hypertension: a review based on the latest clinical guidelines
Areesha Moiz, Tetiana Zolotarova, Mark J. Eisenberg
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 6
Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
Ayesha Rehman, Shahab Saidullah, Muhammad Asad, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 5
Open Access | Times Cited: 6
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Hekai Shi, Merilyn Xie, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1268-1280
Open Access | Times Cited: 6
Fecal Microbiota Transplantation as an Alternative Method in the Treatment of Obesity
Sonali Hemachandra, S. Rathnayake, Anne A Jayamaha, et al.
Cureus (2025)
Open Access
Exploring the therapeutic potential of GLP-1 receptor agonists in the management of obstructive sleep apnea: a comprehensive review
Amruth Akhil Alluri, Matthew Kurien, Nikhil Patel Pokar, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2025)
Closed Access
Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
Andrew Overholser, Eric J. Czech, Linda Speer, et al.
Translation The University of Toledo Journal of Medical Sciences (2025) Vol. 13, Iss. 1
Open Access
Impact of Bariatric Surgery on Postoperative Outcomes, Complications, and Revision Rates in Total Knee Arthroplasty: A Big Data Analysis
David Maman, Guy Eynhoren, Lior Ben-Zvi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1187-1187
Open Access
Effect of semaglutide with obesity or overweight individuals without diabetes: an Umbrella review of systematic reviews
Xiaoye Hu, Yongsheng Wang, Kehu Yang, et al.
Endocrine (2025)
Closed Access
Liposomes Containing Tetraether Lipids and Cell‐Penetrating Peptides as Platform Technology for Oral Delivery of Peptides: A Comparative Study on GLP‐1 Analogs
Lorenz Herbster, Giulia Pander, Manuel Ben Böhmann, et al.
Nano Select (2025)
Open Access
Efficacy and safety of once‐weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus—A systematic review and meta‐analysis of randomized controlled trials
Sharath Kommu, Richard L. Berg
Obesity Reviews (2024) Vol. 25, Iss. 9
Open Access | Times Cited: 4
Metabolically Healthy Obesity: Are Interventions Useful?
Bryan J. Mathis, Kiyoji Tanaka, Yuji Hiramatsu
Current Obesity Reports (2023) Vol. 12, Iss. 1, pp. 36-60
Closed Access | Times Cited: 10
Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists
Ronald Goldenberg, Jeremy Gilbert, Priya Manjoo, et al.
Obesity Reviews (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 10
Semaglutide 2.4 Mg for the Management of Overweight and Obesity: Systematic Literature Review and Meta-Analysis
Inger Smith, EJ Hardy, Stephen Mitchell, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3961-3987
Open Access | Times Cited: 15
Efficacy and safety of tirzepatide in overweight or obese adults without diabetes: systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Milap C. Nahata, Hekai Shi, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top